AstraZeneca announces $50B of investment in U.S. by 2030
Elevate Your Investing Strategy:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Buzz Feed
25 minutes ago
- Buzz Feed
People Share Frustrating Parts Of Today's Beauty Standards
As women in the modern world, it's hard enough dealing with everyday pressures. But on top of that, there's the added stress of having to look a certain way — especially with social media broadcasting idealized versions of faces and bodies. Are people allowed to have fine lines and wrinkles anymore? Be in public without a stitch of makeup? Do we all need to have a perfectly slim waist, but curves in all the other right places? Have rock-hard abs and less than 20% body fat? It's a cycle of trying to find peace, then logging into social media and seeing everyone looking perfect. Ladies, it's time to share your opinon: What are the most frustrating parts of today's beauty standards? Is it the pressure to get Botox and fillers? To fall into a certain weight range with medications like GLP-1s on the rise? Will you share your frustrations with us? Share your thoughts in the comments. For those who prefer to stay anonymous, you can fill out the anonymous form below. Your response may be featured in an upcoming BuzzFeed post.
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
Nasal spray flu vaccine can now be shipped to your home. Here's how to get it
The first nasal spray flu vaccine, FluMist, can now be shipped to your home. FluMist, made by the drug company AstraZeneca, has been approved in the United States since 2003, but its use was limited to health care settings like hospitals and flu clinics. In 2024, the FDA approved it for at-home administration, making it the first nasal spray vaccine approved for widespread use at home. On Friday, AstraZeneca announced a home delivery service for the product, which infectious disease experts hope will lead to more people getting vaccinated against seasonal influenza. The service is available in 34 states including California, for the upcoming 2025-26 flu season. Prior to the approval for at-home use, FluMust had been given mostly in pediatricians' offices because many children have a fear of needles. As many as 2 in 3 children and 1 in 4 adults have a strong fear of needles, according to CDC estimates. Here's what you need to know about the nasal spray vaccine: It's approved for people aged 2 to 49 Adults can self-administer it; it's given through two sprays, one in each nostril. Children should get it administered by a parent or caregiver. You need a prescription Adults can go to to order the vaccine and will be asked to complete a medical screening questionnaire, AstraZeneca said. A licensed health care provider will review the submission to determine eligibility. Once eligibility is confirmed and insurance is verified, the vaccine will be prescribed and shipped directly to consumers' home on the date they selected. It will come with instructions on how to administer, store and dispose the product. Cost Cost will depend on individuals' insurance, but most insurance plans cover flu vaccines at no cost. There is a $8.99 shipping and processing fee per order. It may not be for everyone Anyone who is wheezing, has asthma, has Guillain-Barre syndrome, has a weakened immune system or has problems with the heart, kidneys or lung should check with their health care provider before getting FluMust, according to AstraZeneca. People who are pregnant or nursing, or who have diabetes, should also check with their doctor first. Children under 5 with a history of wheezing should also check with their doctor. Children and adolescents up to 17 years old who are taking aspirin or medicines containing aspirin should not get FluMust. Side effects The most common side effects are runny or stuffy nose, sore throat and fever over 100 degrees.
NBC News
an hour ago
- NBC News
Needle-phobic? FluMist nasal spray vaccine available for use at home
More children died from the flu this past season than any year outside of the swine flu pandemic in 2009. Most of them were unvaccinated. That's why some doctors are hoping that the first nasal flu vaccine available for use at home can improve vaccination rates among people, especially children, who are afraid of needles. AstraZeneca's FluMist Home, which was approved last fall, is now available with a prescription for children ages 2 and over, and adults up to age 49. A 2019 review from researchers at the University of Michigan found the majority of children and up to 30% of young adults are afraid of needles. Dr. Zachary Hoy, board-certified pediatric infectious disease specialist at Pediatrix Medical Group in Nashville, Tennessee, said many children are scared because they aren't old enough to understand what vaccines are and why they are important. 'Most of the time, the anxiety and worry before the shot is scarier than the actual shot,' Hoy said. How does FluMist Home work? The vaccine was first approved in 2003 to be given in a doctor's office. However, after the 2009 swine flu pandemic introduced the new H1N1 strain, several studies found the nasal spray was less effective than other flu vaccines. This prompted the Centers for Disease Control and Prevention to recommend against using the nasal spray in 2016. At the time, the CDC said the nasal spray accounted for one-third of all flu vaccines given to children. In response, FluMist's manufacturers reformulated it to more closely match circulating strains, including H1N1, and the nasal spray returned in 2018. Like injectable flu vaccines, FluMist is updated each season based on recommendations from global health officials. 'FluMist's efficacy is comparable to injectable flu vaccines and is a safe and effective needle-free option for flu protection,' AstraZeneca spokesperson Andrew Leone said. Experts say it's too early to tell how bad the upcoming flu season will be. Typically, flu vaccines are 40% and 60% effective in preventing severe illness, and FluMist Home should be equally protective. The doses for the 2026-2027 season contain three virus strains: an A/H1N1 strain, an A/H3N2 strain and a B strain from the B/Victoria lineage, according to the drugmaker. The FluMist Home vaccine contains a weakened form of a live virus to stimulate the immune system. Pregnant women or people with compromised immune systems are advised to talk with their doctor before using it. Does insurance cover it? FluMist Home is available only online. People ordering the nasal spray will need to complete a medical screening questionnaire at that is reviewed by a health care professional, according to the drugmaker. FluMist Home's online pharmacy will then collect the insurance information and bill the health plan directly. A temperature monitor on the packaging will verify that the vaccine has been maintained at the appropriate temperature during shipping and delivery. Green means it's safe to use. Red means it's not. Christina Aungst, senior pharmacy editor at GoodRx, estimates people with insurance will likely only have to pay an $8.99 shipping fee for the nasal spray. 'Currently, if you don't have insurance, FluMist is only available in a health care setting,' AstraZeneca's Leone said. 'We hope to provide a cash pay option for FluMist Home in future seasons.' When FluMist is given in a health care office or clinic, most insurance plans — including Medicare and Medicaid — will cover it. Dr. Scott Roberts, associate medical director of infection prevention at Yale School of Medicine, worries people may not administer the nasal spray vaccine properly without a doctor's supervision. 'What if they have a runny nose? How far back do they need to spray in the nose? What if they store it incorrectly in their house?' Roberts asked. Dr. Kristina Bryant, pediatric infectious diseases physician at Norton Children's in Louisville, Kentucky, and a member of the American Academy of Pediatrics Committee on Infectious Diseases, said the bottom line is that all the available flu vaccines offer comparable protection. 'The most important thing to know is that vaccines only work if they are actually administered,' Bryant said. 'Hopefully, the availability of a vaccine that can be administered in the home will make it easier for some people to be protected against flu.'
